| Kin S. YANG; Hang CHU; Solomon H. REISBERG; Wai Yan CHOY; Brian P. BESTVATER et al. (2025). Reversible lysine covalent modifiers of cdk2 and uses thereof. Patent Number: WO2025090658. |
CMCF-ID |
Patent |
Health |
| Kelsey Sivick GAUTHIER; Nigel Pelham Clinton Walker; Xiaoning ZHAO; John Lippincott (2024). Antibodies to tigit. Patent Number: US20240182570A1. |
CMCF-ID |
Patent |
Health |
| Judit Anido Folgueira; Patricia Anne Giblin; Robin Matthew Hallett; Jeanne Magram; Naimish PANDYA et al. (2024). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: AU2024204564A1. |
CMCF-ID |
Patent |
Health |
| Juan P. Ianowski; Julian S. Tam; Xiaojie Luan; Veronica A. Campanucci (2021). Neuronal agonists and isotonic or hypertonic saline for treating respiratory diseases. Patent Number: US20210228511A1. |
BMIT-BM |
Patent |
Health |
| Jorg Stetefeld (2020). Netrin- 1 and dependence receptor proteins and method of use. Patent Number: US20200165308A1. |
CMCF-BM |
Patent |
Health |
| Jorg Stetefeld (2016). Netrin-1 and dependence receptor proteins and methods of use. Patent Number: US20160355560A1. |
CMCF-BM |
Patent |
Health |
| Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Robin Matthew Hallett; Peter Edward BAYLISS; Ajitha JEGANATHAN et al. (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: US20210253691A1. |
CMCF-ID |
Patent |
Health |
| Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Robin Matthew Hallett; Patricia Anne GIBLIN; Jeanne MAGRAM et al. (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: US20210187106A1. |
CMCF-ID |
Patent |
Health |
| Joan Seoane Suarez; Judit Anido Folgueira; Patricia Anne GIBLIN; Peter Edward BAYLISS; Johan Fransson et al. (2019). Methods of quantifying lif and uses thereof. Patent Number: WO2019243893A1. |
CMCF-ID |
Patent |
Health |
| Joan Seoane Suarez; Judit Anido Folgueira; Johan Fransson; Robin Matthew HALETT; Monica PASCUAL GARCIA et al. (2019). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: WO2019197903A1. |
CMCF-ID |
Patent |
Health |
| Joan Seoane Suarez; Judit Anido Folgueira; Johan Fransson; Jean-Philippe Julien; Swetha RAMAN et al. (2018). Antibodies against lif and uses thereof. Patent Number: US20180169233A1. |
CMCF-ID |
Patent |
Health |
| J. Michael ELLIOTT; Justin Scheer (2012). Fc VARIANTS AND METHODS FOR THEIR PRODUCTION. Patent Number: WO2012106587A1. |
CMCF-ID |
Patent |
Health |
| Jehad ABED; Steven Thorpe; Edward Sargent (2025). Electrocatalysts comprising transition metals and chalcogen for oxygen evolution reactions (OER) and manufacturing thereof. Patent Number: US12234157B2. |
CLS-APS, SGM |
Patent |
Materials |
| Jehad ABED; Steven Thorpe; Edward Sargent (2025). Electrocatalysts comprising transition metals and chalcogen for oxygen evolution reactions (OER) and manufacturing thereof. Patent Number: US12234157B2. |
CLS-APS, SGM |
Patent |
Materials |
| Jean-Philippe Julien; Taylor Sicard; Anthony Semesi; Bebhinn Treanor; Tiantian Zhao et al. (2025). Nanoparticle platform for antibody and vaccine delivery. Patent Number: US20250114475A1. |
CMCF-ID |
Patent |
Health |